Publications by authors named "Sugiura W"

This study presents a retrospective assessment of the diagnostic performance of the newly developed hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) in detecting plasma samples with elevated hepatitis B virus (HBV) DNA levels (≥200,000 IU/ml) in Yaoundé, Cameroon. Samples were collected consecutively from treatment-naïve adults living with HBV between January 1, 2021, and June 30, 2023. Analyzing 146 samples from participants with a median age of 36 years, the HBcrAg-RDT exhibited a sensitivity of 97.

View Article and Find Full Text PDF

Background: Data are limited on the protective role of the Omicron BA bivalent vaccine, previous infection, and their induced neutralizing antibodies against Omicron XBB.1.16 and EG.

View Article and Find Full Text PDF

Eight peaks of coronavirus disease 2019 (COVID-19) outbreak occurred in Japan, each associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. The National Epidemiological Surveillance of Infectious Diseases (NESID) analyzed viral genome sequences from symptomatic patients and submitted the results to GISAID. Meanwhile, commercial testing services occasionally sequence samples from asymptomatic individuals.

View Article and Find Full Text PDF

Background: We aimed to examine the association among nucleocapsid (N) antibodies, a combination of N and spike (S) antibodies, and protection against SARS-CoV-2 reinfection.

Methods: We conducted a prospective cohort study among staff at a national medical research center in Tokyo and followed them for the incidence of SARS-CoV-2 infection between June and September 2023 (Omicron XBB.1.

View Article and Find Full Text PDF

Within the protein interior, where we observe various types of interactions, nonuniform flow of thermal energy occurs along the polypeptide chain and through nonbonded native contacts, leading to inhomogeneous transport efficiencies from one site to another. The folded native protein serves not merely as thermal transfer medium but, more importantly, as sophisticated molecular nanomachines in cells. Therefore, we are particularly interested in what sort of "communication" is mediated through native contacts in the folded proteins and how such features are quantitatively depicted in terms of local transport coefficients of heat currents.

View Article and Find Full Text PDF

Background & Aims: Vitamin D deficiency is a common nutritional problem worldwide that may have worsened during the coronavirus disease 2019 (COVID-19) pandemic. The present study sought to examine the prevalence and correlates of vitamin D deficiency among healthcare workers three years after the start of the COVID-19 pandemic.

Methods: Participants comprised 2543 staff members from a medical research institute, who completed a questionnaire and donated blood samples in June 2023.

View Article and Find Full Text PDF
Article Synopsis
  • - This study assessed how accurately SARS-CoV-2 RNA can be detected in saliva samples, comparing those treated with guanidine and without, against traditional nasopharyngeal swabs (NPS) used as a reference.
  • - Results showed that raw saliva had a 100% sensitivity for detecting the virus, while the sensitivity for saliva treated with guanidine-based and guanidine-free inactivators was lower, at 65.9% and 82.9% respectively.
  • - Despite the reduced sensitivity in treated saliva, the study found that these inactivated samples could still provide reliable results for diagnosing COVID-19, which is beneficial for minimizing the risk of virus transmission.
View Article and Find Full Text PDF
Article Synopsis
  • APTs (adaptive platform trials) allow multiple drugs to be tested against a common control group, offering flexibility as drugs can be added or removed during the trial based on ongoing results.
  • A simulation study comparing APTs to traditional stand-alone trials for COVID-19 showed that APTs generally have a shorter total development period, but this advantage can decrease if patient enrollment speeds up as infection rates rise.
  • While APTs can enhance efficiency in drug development without compromising statistical validity, their effectiveness relies on various factors like patient enrollment speed, sample size, error adjustments, and trial design, necessitating careful planning during a pandemic.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the LC16m8 vaccine's safety and effectiveness against the monkeypox virus (MPXV) in 50 healthy adults over 168 days.
  • On day 28, the vaccine showed strong immunogenicity, with 72% to 88% seroconversion rates, although these rates declined by day 168.
  • Adverse events were common but mostly mild, and no serious safety issues or cases of monkeypox were reported during the study period.
View Article and Find Full Text PDF

Delays in clearance and rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in immunocompromised patients. We encountered a case of recurrent, multi-mutational SARS-CoV-2 infection in a 40-year-old man with severe immunodeficiency due to Good syndrome. The patient had not received the SARS-CoV-2 vaccination.

View Article and Find Full Text PDF

Background: HBV DNA integration into the host genome is frequently found in HBV-associated HCC tissues and is associated with hepatocarcinogenesis. Multiple detection methods, including hybrid capture-sequencing, have identified integration sites and provided clinical implications; however, each has advantages and disadvantages concerning sensitivity, cost, and throughput. Therefore, methods that can comprehensively and cost-effectively detect integration sites with high sensitivity are required.

View Article and Find Full Text PDF

Antipyretic analgesics are used to manage and control symptoms occurring after vaccination, but may hamper immunogenicity or vaccine efficacy. We examined the association between prophylactic or therapeutic use of antipyretic analgesics and SARS-CoV-2 antibody titers for vaccine recipients. Data were obtained from 1,498 staff members of a medical and research institution in Tokyo, Japan, who had received the second dose of the BNT162b2 vaccine.

View Article and Find Full Text PDF

Background: Integrase strand transfer inhibitors (INSTIs) are recommended as first-line ART for people living with HIV (PLWH) in most guidelines. The INSTI-resistance-associated mutation E157Q, a highly prevalent (2%-5%) polymorphism of the HIV-1 (human immunodeficiency virus type 1) integrase gene, has limited data on optimal first-line ART regimens. We assessed the virological outcomes of various first-line ART regimens in PLWH with E157Q in real-world settings.

View Article and Find Full Text PDF

Background: Data are limited on the role of preinfection humoral immunity protection against Omicron BA.5 infection and long coronavirus disease (COVID) development.

Methods: We conducted nested case-control analysis among tertiary hospital staff in Tokyo who donated blood samples in June 2022 (1 month before Omicron BA.

View Article and Find Full Text PDF

 • Human immunodeficiency virus (HIV) drug resistance has implications for antiretroviral treatment strategies and for containing the HIV pandemic because the development of HIV drug resistance leads to the requirement for antiretroviral drugs that may be less effective, less well-tolerated, and more expensive than those used in first-line regimens.  • HIV drug resistance studies are designed to determine which HIV mutations are selected by antiretroviral drugs and, in turn, how these mutations affect antiretroviral drug susceptibility and response to future antiretroviral treatment regimens.  • Such studies collectively form a vital knowledge base essential for monitoring global HIV drug resistance trends, interpreting HIV genotypic tests, and updating HIV treatment guidelines.

View Article and Find Full Text PDF

Background: In May 2022, a case of monkeypox (currently known as "mpox") with no history of overseas travel was reported in the United Kingdom, followed by reports of infections reported in Europe, the United States, and other countries worldwide. Due to the significant overlap in immune responses among viruses of the genus Orthopoxvirus (including smallpox virus, mpox virus, and vaccinia virus), it is believed that cross-immunity can be achieved by administering the smallpox virus vaccine. In Japan, a smallpox vaccine (LC16m8 strain vaccine) has been approved; however, there was no regulatory approval for the mpox vaccine during the design of this study.

View Article and Find Full Text PDF
Article Synopsis
  • * A study investigated the safety and effectiveness of post-exposure prophylaxis using a smallpox vaccine in individuals who were in close contact with mpox patients, with participants inoculated within 14 days after exposure.
  • * No symptoms of mpox were seen in vaccinated participants during the 21-day follow-up, though some mild side effects from the vaccine were noted, leading to the conclusion that the smallpox vaccine can effectively protect against mpox after exposure, though more studies are needed.
View Article and Find Full Text PDF

Although thermal transport is among the essential biophysical properties of proteins, its relationship with protein structures, dynamics, and functions is still elusive. The structures of folded proteins are highly inhomogeneous, giving rise to an anisotropic and non-uniform flow of thermal energy during conformational fluctuations. To illustrate the nature of proteins, we developed a theoretical framework for analyzing local thermal transport properties based on the autocorrelation function formalism, constructed a linear-homopolymer-like model, and applied it to a small α-helical protein, the villin headpiece subdomain (HP36), using equilibrium molecular dynamics simulations.

View Article and Find Full Text PDF

Objectives: To examine the differences in durability and its determinants of humoral immunity following 2- and 3-dose COVID-19 vaccination.

Methods: Throughout the pandemic, we evaluated the anti-spike IgG antibody titers of 2- and 3-dose mRNA vaccine recipients over time among the staff of a medical and research center in Tokyo. Linear mixed models were used to estimate trajectories of antibody titers from 14 to 180 days after the last immune-conferred event (vaccination or infection) and compare antibody waning rates across prior infection and vaccination status, and across background factors in infection-naïve participants.

View Article and Find Full Text PDF
Article Synopsis
  • - Late HIV diagnosis in Japan is a significant issue, particularly among young men who have sex with men (MSM) in urban areas, and the study aimed to understand various factors contributing to this problem, including demographics and clinical aspects.
  • - The research analyzed anonymized data from nearly 10,000 newly diagnosed HIV cases from 2003 to 2019, revealing that 71.2% of participants experienced late diagnosis, with a median CD4 count of 221 cells/μl at diagnosis.
  • - Key factors linked to late HIV diagnosis included older age, heterosexual transmission, living outside of Tokyo, co-infection with hepatitis C, and not being part of a genetic cluster, while a specific HIV subtype (CRF
View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the effectiveness of convalescent plasma therapy for COVID-19 in high-risk patients who showed symptoms within five days.
  • The trial involved 25 patients, with no significant difference in viral load changes between those receiving convalescent plasma and those receiving standard care over the first five days.
  • The results suggest that early convalescent plasma treatment does not reduce SARS-CoV-2 viral load compared to standard care alone within that timeframe.
View Article and Find Full Text PDF

Background: Longitudinal data are lacking to compare booster effects of Delta breakthrough infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron.

Methods: Participants were the staff of a national research and medical institution in Tokyo who attended serological surveys on June 2021 (baseline) and December 2021 (follow-up); in between, the Delta-dominant epidemic occurred. Of 844 participants who were infection-naïve and had received two doses of BNT162b2 at baseline, we identified 11 breakthrough infections during follow-up.

View Article and Find Full Text PDF